Specialized Centers in Research in Pediatric Developmental Pharmacology (U54)

Funding Agency:
National Institutes of Health

The purpose of this funding opportunity announcement (FOA) is to announce the re-competition of the Research in Pediatric Developmental Pharmacology Centers Program (RPDP).  The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) proposes to fund a limited number of research Centers which will provide an arena for multidisciplinary interactions between basic and clinical scientists interested in establishing high quality translational research programs in the area of pediatric developmental pharmacology. The Centers also will serve as a national resource for the education of new scientists electing to pursue careers in the conduct of translational research in high priority areas of pediatric developmental pharmacology. Finally, Center investigators will facilitate important community outreach and education efforts to increase awareness and convey the importance and implications of their research activities to the general public.


  • Letter of Intent Due Date(s): January 18, 2016
  • Application Due Date(s): February 18, 2016, by 5:00 PM local time of applicant organization.

​RFA-HD-16-014 Expiration Date February 19, 2016

Agency Website



Amount Description

Direct costs are limited to $500,000 per year.

The total project period may not exceed five years.

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

February 18, 2016